|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
Clarity on Clinical Investigations: What You Need to Know About EU-MDR and ISO/DIS 14155:2018
Want to attend the live webinar on Sept. 19? Click here to register.
The world of clinical investigations is changing rapidly, with the EU-MDR’s new and more complex system and the forthcoming ISO/DIS 14155:2018 updates.
This presentation will provide insight into the EU-MDR’s extensive requirements for documenting, conducting and reporting clinical investigations, including which devices are exempt. Manufacturers of non-exempt devices must set up a clinical investigation system using both EU-MDR and ISO/DIS 14155:2018. The interplay between the two is explained through an exploration of Annex ZC.
Why not let noted expert, Dan O’Leary, explain these requirements and concepts in his comprehensive, easy-to-understand approach? Mr. O’Leary, President of Ombu Enterprises, LLC, will provide valuable insight into the EU-MDR’s extensive requirements for documenting, conducting and reporting clinical investigations, including which devices are exempt.
By attending this presention, you’ll:
Make sure you fully understand the EU-MDR’s and ISO/DIS 14155:2018’s clinical investigation requirements — how they work together and how to make them work for you.
Dan O’Leary is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Mr. O’Leary has more than 30 years’ experience in quality, operations and program management in regulated industries including medical devices and clinical laboratories. He has a Masters Degree in Mathematics; is an ASQ-certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer and Six Sigma Black Belt; and is certified by APICS in Resource Management.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing